Raymond James Financial Services Advisors Inc. Trims Stock Holdings in Tilray Inc (NASDAQ:TLRY)

Raymond James Financial Services Advisors Inc. trimmed its holdings in Tilray Inc (NASDAQ:TLRY) by 2.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 71,246 shares of the company’s stock after selling 2,011 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Tilray were worth $804,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. 1832 Asset Management L.P. purchased a new stake in shares of Tilray in the second quarter worth approximately $29,000. Banque Cantonale Vaudoise increased its holdings in Tilray by 157.6% during the 3rd quarter. Banque Cantonale Vaudoise now owns 2,602 shares of the company’s stock worth $29,000 after purchasing an additional 1,592 shares during the period. US Bancorp DE increased its holdings in Tilray by 247.9% during the 2nd quarter. US Bancorp DE now owns 2,251 shares of the company’s stock worth $41,000 after purchasing an additional 1,604 shares during the period. Covington Capital Management purchased a new position in Tilray during the 2nd quarter worth $45,000. Finally, BDO Wealth Advisors LLC increased its holdings in Tilray by 802.1% during the 2nd quarter. BDO Wealth Advisors LLC now owns 3,383 shares of the company’s stock worth $61,000 after purchasing an additional 3,008 shares during the period. Hedge funds and other institutional investors own 12.09% of the company’s stock.

TLRY has been the topic of several research reports. reduced their price objective on Tilray from $17.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, October 8th. MKM Partners reduced their price objective on Tilray from $10.00 to $8.00 and set a “neutral” rating on the stock in a report on Tuesday. Cantor Fitzgerald dropped their target price on Tilray from $11.80 to $7.40 and set a “neutral” rating on the stock in a research report on Friday, January 7th. Zacks Investment Research raised Tilray from a “sell” rating to a “hold” rating in a research report on Wednesday, December 22nd. Finally, Stifel Nicolaus dropped their target price on Tilray from $11.50 to $10.00 and set a “hold” rating on the stock in a research report on Friday, October 8th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $13.62.

Tilray stock opened at $6.86 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.25 and a quick ratio of 1.13. The stock has a market capitalization of $3.16 billion, a price-to-earnings ratio of -3.59 and a beta of 2.39. Tilray Inc has a 1-year low of $6.29 and a 1-year high of $67.00. The business has a fifty day moving average price of $9.07 and a 200-day moving average price of $11.64.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Monday, January 10th. The company reported $0.03 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.12. The firm had revenue of $155.10 million during the quarter, compared to analysts’ expectations of $171.57 million. Tilray had a negative return on equity of 2.57% and a negative net margin of 66.64%. The company’s revenue was up 19.8% compared to the same quarter last year. On average, equities research analysts anticipate that Tilray Inc will post -0.24 earnings per share for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Read More: Different Options Trading Strategies

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.